You have 9 free searches left this month | for more free features.

MF

Showing 26 - 50 of 5,757

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Asthma Trial (MF/F Metered Dose Inhaler (MDI) 25/5 mcg, MF/F MDI 50/5 mcg, MF/F MDI 100/5 mcg)

Withdrawn
  • Asthma
  • MF/F Metered Dose Inhaler (MDI) 25/5 mcg
  • +6 more
  • (no location specified)
Feb 7, 2022

Myelofibrosis, Chronic Myelomonocytic Leukemia Trial in Canada, United States (SL-401)

Active, not recruiting
  • Myelofibrosis
  • Chronic Myelomonocytic Leukemia
  • Duarte, California
  • +9 more
Jan 24, 2023

Asthma Trial (MF)

Completed
  • Asthma
  • MF
  • (no location specified)
Feb 1, 2022

COPD (COPD) Trial (Mometasone furoate/formoterol (MF/F) combination, Mometasone furoate MDI (MF MDI), Formoterol MDI)

Completed
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Mometasone furoate/formoterol (MF/F) combination
  • +3 more
  • (no location specified)
Feb 7, 2022

Asthma, COPD Trial (SCH No. 418131 (Mometasone Furoate/Formoterol Furoate abbreviated MF/F ))

Completed
  • Asthma
  • COPD
  • SCH No. 418131 (Mometasone Furoate/Formoterol Furoate abbreviated MF/F )
  • (no location specified)
Feb 7, 2022

Asthma Trial in Nagykanizsa, George, Cape Town (Mometasone furoate, QMF149)

Completed
  • Asthma
  • Nagykanizsa, Hungary
  • +2 more
May 16, 2022

Lifetech MFO Post-Market Clinical Follow-Up Study

Recruiting
  • Ventricular Septal Defect
  • KONAR-MF™ VSD Occluder
  • Bad Oeynhausen, Germany
  • +3 more
Nov 24, 2021

Myelofibrosis, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Charlottesville (Tagraxofusp)

Recruiting
  • Myelofibrosis
  • +2 more
  • Charlottesville, Virginia
    Danyelle Coley
Jan 18, 2023

Sezary Syndrome, Mycosis Fungoides Trial in Stanford (Mogamulizumab, LD TSEBT)

Recruiting
  • Sezary Syndrome
  • Mycosis Fungoides
  • Stanford, California
    Stanford Cancer Center
Oct 19, 2022

Influenza (Healthy Volunteers) Trial in United States (Panblok + MF59 Dose 1, Panblok + MF59 Dose 2, Unadjuvanted Panblok Dose

Recruiting
  • Influenza (Healthy Volunteers)
  • Panblok + MF59 Dose 1
  • +2 more
  • Mesa, Arizona
  • +15 more
Nov 9, 2022

Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary Myelofibrosis, Secondary Myelofibrosis Trial in Houston

Completed
  • Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
May 27, 2022

HIV Trial in Rochester (MTP-PE/MF59, Env 2-3)

Completed
  • HIV Infections
  • MTP-PE/MF59
  • Env 2-3
  • Rochester, New York
    Univ. of Rochester AVEG
Oct 27, 2021

Anorexia Nervosa Trial in Palo Alto (Multi-Family Guided Self-Help FBT)

Recruiting
  • Anorexia Nervosa
  • Multi-Family Guided Self-Help FBT
  • Palo Alto, California
    Stanford University
Jun 30, 2022

HIV, HIV Seronegativity Trial in Rochester, Nashville, Seattle (MTP-PE/MF59, Env 2-3)

Completed
  • HIV Infections
  • HIV Seronegativity
  • MTP-PE/MF59
  • Env 2-3
  • Rochester, New York
  • +2 more
Oct 28, 2021

SARS-CoV-2 Trial in Melbourne (Adjuvanted SARS-CoV-2 beta variant RBD recombinant protein vaccine (DoCo-Pro-RBD-1 + MF59),

Recruiting
  • SARS-CoV-2
  • Adjuvanted SARS-CoV-2 beta variant RBD recombinant protein vaccine (DoCo-Pro-RBD-1 + MF59)
  • +2 more
  • Melbourne, Victoria, Australia
  • +1 more
Apr 25, 2022

Influenza, Human Trial (Investigational aQIVc, licensed QIV1, licensed QIV2)

Not yet recruiting
  • Influenza, Human
  • Investigational aQIVc
  • +2 more
  • (no location specified)
Aug 28, 2023

Characterize Patients Initiating Enerzair® Breezhaler®, With or

Withdrawn
  • Asthma
  • IND/GLY/MF
  • (no location specified)
Mar 22, 2022

Mycosis Fungoides Trial in Leiden (Chlormethine)

Recruiting
  • Mycosis Fungoides
  • Leiden, Netherlands
    Centre for Human Drug Research
Mar 29, 2022

Cutaneous T Cell Lymphoma, Mycosis Fungoides Trial (Mogamulizumab, Brentuximab vedotin)

Not yet recruiting
  • Cutaneous T Cell Lymphoma
  • Mycosis Fungoides
  • (no location specified)
Dec 7, 2022

Asthma Trial (Mometasone furoate dry powder inhaler, Placebo)

Completed
  • Asthma
  • Mometasone furoate dry powder inhaler
  • Placebo
  • (no location specified)
Feb 7, 2022

Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides/Sezary Syndrome Trial in Zürich (Methoxsalen, THERAKOS CELLEX Photopheresis

Withdrawn
  • Lymphoma, T-Cell, Cutaneous
  • Mycosis Fungoides/Sezary Syndrome
  • Zürich, Switzerland
    UniversitaetsSpital Zurich - Division of Dermatology
Aug 31, 2021

Cataract Trial in Wenzhou (SN6AD1, SBL-3, LS-313 MF30)

Recruiting
  • Cataract
  • SN6AD1
  • +5 more
  • Wenzhou, Zhejiang, China
    The Eye Hispital of Wenzhou Medical University
Oct 4, 2021

Primary Myelofibrosis, Secondary Myelofibrosis, PMF Trial in Germany (INCB018424/CC-4047)

Active, not recruiting
  • Primary Myelofibrosis
  • +5 more
  • Aachen, Germany
  • +16 more
Sep 28, 2021